These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32821697)

  • 1. Established and Emerging Mechanisms of Diabetic Cardiomyopathy.
    Gollmer J; Zirlik A; Bugger H
    J Lipid Atheroscler; 2019 May; 8(1):26-47. PubMed ID: 32821697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
    Hölscher ME; Bode C; Bugger H
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.
    Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM
    Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
    Jia G; Hill MA; Sowers JR
    Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Role do Mitochondria Have in Diastolic Dysfunction? Implications for Diabetic Cardiomyopathy and Heart Failure With Preserved Ejection Function.
    McCandless MG; Altara R; Booz GW; Kurdi M
    J Cardiovasc Pharmacol; 2022 Apr; 79(4):399-406. PubMed ID: 35179855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
    Seferović PM; Paulus WJ
    Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
    Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T
    Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.
    Paulus WJ; Dal Canto E
    JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Animal Models in Diabetic Cardiomyopathy.
    Lee WS; Kim J
    Diabetes Metab J; 2021 Mar; 45(2):129-145. PubMed ID: 33813812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying diabetic cardiomyopathy: From pathophysiology to novel therapeutic targets.
    Cong S; Ramachandra CJA; Mai Ja KM; Yap J; Shim W; Wei L; Hausenloy DJ
    Cond Med; 2020 Apr; 3(2):82-97. PubMed ID: 34169234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.
    De Jong KA; Lopaschuk GD
    Can J Cardiol; 2017 Jul; 33(7):860-871. PubMed ID: 28579160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management.
    Meagher P; Adam M; Civitarese R; Bugyei-Twum A; Connelly KA
    Can J Cardiol; 2018 May; 34(5):632-643. PubMed ID: 29731023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.
    Tschöpe C; Van Linthout S; Kherad B
    Curr Cardiol Rep; 2017 Aug; 19(8):70. PubMed ID: 28656481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal Muscle Alterations Are Exacerbated in Heart Failure With Reduced Compared With Preserved Ejection Fraction: Mediated by Circulating Cytokines?
    Seiler M; Bowen TS; Rolim N; Dieterlen MT; Werner S; Hoshi T; Fischer T; Mangner N; Linke A; Schuler G; Halle M; Wisloff U; Adams V
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27609832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic Cardiomyopathy; Summary of 41 Years.
    Yilmaz S; Canpolat U; Aydogdu S; Abboud HE
    Korean Circ J; 2015 Jul; 45(4):266-72. PubMed ID: 26240579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms.
    Salvatore T; Pafundi PC; Galiero R; Albanese G; Di Martino A; Caturano A; Vetrano E; Rinaldi L; Sasso FC
    Front Med (Lausanne); 2021; 8():695792. PubMed ID: 34277669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
    Huynh K; Bernardo BC; McMullen JR; Ritchie RH
    Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
    Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.